video thumbnail

Epstein Barr Virus Reactivation in COVID

Duration: 23:28

Write A New Comment


Epstein Barr Virus Reactivation in COVID

A study from China published in May 2021 concluded: We find a high incidence of EBV coinfection in COVID-19 patients. EBV/SARS-CoV-2 coinfection was associated with fever and increased inflammation. EBV reactivation may be associated with the severity of COVID-19. The reactivation of EBV may also be the cause of the COVID long haul symptoms. Let's review.

About infectious Mononucleosis

Study published in nature on May 21st 2021

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.


Related Videos